CIK 0001434316
- Non-accelerated filer
- Smaller reporting company
FATE THERAPEUTICS INC
Sign in to watch- Ticker
- FATE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 651311552
- Phone
- +1 858-875-1803
- Business address
- 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, 92131
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,525
- in 1 filing
Net −$13,525. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-11 | TAHL CINDY General Counsel and Secretary | Sale | −1,050 | $110.76 | $116K | 90,907 |
| 2021-01-11 | TAHL CINDY General Counsel and Secretary | Sale | −872 | $109.65 | $96K | 90,035 |
| 2021-01-11 | Shoemaker Daniel D Chief Scientific Officer | Sale | −1,332 | $111.62 | $149K | 85,530 |
| 2021-01-11 | Shoemaker Daniel D Chief Scientific Officer | Sale | −1,050 | $110.76 | $116K | 84,480 |
| 2021-01-11 | Shoemaker Daniel D Chief Scientific Officer | Sale | −871 | $109.65 | $96K | 83,609 |
| 2021-01-08 | Wolchko J Scott President and CEO | Sale | −26,904 | $117.60 | $3.2M | 393,065 |
| 2021-01-08 | Wolchko J Scott President and CEO | Sale | −23,932 | $117.15 | $2.8M | 369,133 |
| 2021-01-08 | Wolchko J Scott President and CEO | Sale | −8,515 | $115.80 | $986K | 360,618 |
| 2021-01-08 | Wolchko J Scott President and CEO | Sale | −1,469 | $114.76 | $169K | 359,149 |
| 2021-01-08 | Valamehr Bahram Chief Development Officer | Sale | −2,756 | $117.60 | $324K | 84,455 |
| 2021-01-08 | Valamehr Bahram Chief Development Officer | Sale | −2,451 | $117.15 | $287K | 82,004 |
| 2021-01-08 | Valamehr Bahram Chief Development Officer | Sale | −872 | $115.80 | $101K | 81,132 |
| 2021-01-08 | Valamehr Bahram Chief Development Officer | Sale | −151 | $114.76 | $17K | 80,981 |
| 2021-01-08 | TAHL CINDY General Counsel and Secretary | Sale | −2,755 | $117.60 | $324K | 96,763 |
| 2021-01-08 | TAHL CINDY General Counsel and Secretary | Sale | −2,451 | $117.15 | $287K | 94,312 |
| 2021-01-08 | TAHL CINDY General Counsel and Secretary | Sale | −872 | $115.80 | $101K | 93,440 |
| 2021-01-08 | TAHL CINDY General Counsel and Secretary | Sale | −151 | $114.76 | $17K | 93,289 |
| 2021-01-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −2,755 | $117.60 | $324K | 90,336 |
| 2021-01-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −2,451 | $117.15 | $287K | 87,885 |
| 2021-01-08 | Shoemaker Daniel D Chief Scientific Officer | Sale | −872 | $115.80 | $101K | 87,013 |
Page 25 of 26 · 503 trades